News

From concerning statistics on global health outcomes to new insights on AI and RWD, explore the top pharma news from July ...
Shanghai-based Zhongshan Hospital, affiliated with Fudan University, where many of the Chinese experts leading global liver ...
If included in National List of Essential Medicines (NLEM), the fixed-dose combinations (FDCs) to rein in hypertension can be ...
ASPIRE-BioNEST at UoH and Tulsi Therapeutics announce world’s first successful pre-clinical trial of Stem Cell–Exosome ...
A new study in The Journal of Sexual Medicine found that participating in “No Nut November”, a month-long abstinence ...
Why does it take years to diagnose dementia? A study finds that on average, it takes 3.5 years after symptoms first appear to ...
Sette added that like rodents, cockroaches produce important allergens, particularly in under-resourced urban settings.
Tulsi Therapeutics achieves groundbreaking success with novel stem cell–exosome therapy for chronic liver failure at ...
CCRAS announces second edition of scientific writing workshop: Our Bureau, New Delhi Monday, July 28, 2025, 09:00 Hrs [IST] The Central Council for Research in Ayurvedic Sciences ...
In a landmark moment for India’s biotechnology sector, Hyderabad-based biotech startup Tulsi Therapeutics, which focused on regenerative medicine using stem cells and exosomes, and ASPIRE-BioNEST, ...
New research from scientists at the Marshall University Joan C. Edwards School of Medicine reveals that certain gut microbial ...
ViaLase Inc., a glaucoma-focused medtech startup, is changing up its leadership ahead of planned commercial launch in the U.S ...